Related Experiment Video

Updated: May 11, 2026

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

MicroRNA biomarkers in glioblastoma

Simon Kjær Hermansen1, Bjarne Winther Kristensen

  • 1Department of Pathology, Odense University Hospital, Winsløwparken 15, 3. Floor, 5000, Odense C, Denmark. simon.hermansen@rsyd.dk

Journal of Neuro-Oncology
|May 24, 2013
PubMed

Insights

MicroRNAs (miRNAs) show altered expression in glioblastoma, offering potential as cancer biomarkers. Understanding these changes is crucial for developing new diagnostic and therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are short non-coding RNA sequences involved in gene regulation.
  • Deregulation of miRNAs is implicated in the initiation and progression of various cancers, including gliomas.
  • Aberrant miRNA expression is observed in glioblastoma compared to normal brain tissues.

Purpose of the Study:

  • To review current knowledge on miRNA alterations in glioblastoma.
  • To focus on the clinical potential of miRNAs as biomarkers for glioblastoma.
  • To discuss methods for evaluating miRNA expression in glioblastoma.

Main Methods:

  • Literature review of recent research on miRNAs in glioblastoma.
  • Analysis of studies profiling miRNA expression in clinical glioblastoma samples.
  • Discussion of strengths and weaknesses of different miRNA expression evaluation techniques.

Main Results:

  • Numerous miRNAs exhibit aberrant expression in glioblastoma.
  • miRNAs demonstrate potential as diagnostic and therapeutic tools in cancer.
  • Understanding miRNA alterations is key for developing novel biomarkers and treatment strategies.

Conclusions:

  • miRNA deregulation is a significant factor in glioblastoma.
  • miRNAs hold promise as clinical biomarkers for glioblastoma.
  • Further research into miRNA expression analysis methods is warranted for clinical application.

More Related Videos

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...